Oncologist Explains PSA Screening as Prostate Cancer Cases Top 330,000 in 2026

3 articles · Updated · The Washington Post · Aug 31

More than 330,000 new prostate cancer cases are estimated for 2026, prompting renewed attention to PSA blood testing and why doctors do not automatically order it for every man.
PSA screening can help detect prostate cancer before symptoms appear, but the disease often grows slowly, making routine testing a more individualized decision than many patients expect.
Prostate cancer accounts for nearly one-third of invasive cancers in men and ranks as the fifth leading cause of male cancer-related deaths worldwide.
The guidance underscores a central screening dilemma: a common, often symptomless cancer can be detectable early, yet universal regular testing is not presented as automatic care.